미래를 선도하는 원료의약품 전문업체 주식회사 하이플

“Challenge”, “Creativity” and “Exploration”

Since the establishment of “Kangsan Pharmaceuticals” in 1999,
we have arrived until now under principles of “Challenge”, “Creativity” and “Exploration”

2021 ~ Present
- 2023.08 Highfly Co., Ltd. signed an exclusive supply agreement for Kallidinogenase API
- 2023.12 Acquired DID Bio Co., Ltd.
- 2024.07 Signed MOU with Daeryun Law Firm for medical and legal advisory services
- 2024.07 Company name changed from DID Bio Co., Ltd. to Highfly Life Science Co., Ltd.
- 2025.02 Filed patent application for the synthesis method of Alogliptin Benzoate (antidiabetic agent)
- 2025.11 Completed patent registration for the synthesis method of Ilaprazole (anti-peptic ulcer agent)
- 2026.01 Mr. Youngjin Kwon appointed as President
- 2026.03 Filed patent application for synthesis research of Fexuprazan (anti-peptic ulcer agent)
2011 ~ 2020
- 2012.12 Signed joint research agreement with the Agri-Bio Industry Consortium
- 2013.07 Divested Pharmswell Bio Co., Ltd.
- 2015.07 Established Pharmsgen Co., Ltd. and obtained pharmaceutical wholesale license
- 2015.12 Obtained pharmaceutical import license (Pharmsgen Co., Ltd.)
- 2019.03 Awarded Exemplary Taxpayer (Bundang District Tax Office)
- 2019.05 Relocated headquarters (from Yangjae-dong to Pangyo, Unjung-dong)
- 2019.07 Company name changed from Pharmsgen Co., Ltd. to Highfly Co., Ltd.
- 2019.08 Certified as a Venture Company (Korea Technology Finance Corporation)
- 2019.08 Obtained INNO-BIZ certification (Ministry of SMEs and Startups)
2006 ~ 2010
- 2006.06 Certified as a Venture Company
- 2006.10 Obtained INNO-BIZ certification
- 2007.01 Company name changed from Kangsan Pharmaceutical Co., Ltd. to Pharmswell Co., Ltd.
- 2007.02 CEO Youngjin Kwon received the Minister of Health and Welfare Award
- 2007.03 Certified as a corporate-affiliated research institute
- 2007.04 Relocated and expanded central research center
- 2007.10 Received Grand Prize for Venture Companies (awarded by the Small and Medium Business Administration)
- 2007.11 Selected as Kibo A+ Members company and certified with Technology Rating Grade A
- 2008.03 Acquired KobioTech Co., Ltd.
- 2008.06 Company name changed to Pharmswell Bio Co., Ltd.
2000 ~ 2005
- 2000.08 Designated as a KGSP (Korea Good Supply Practice) certified company
- 2001.07 Established ChemPro Co., Ltd., a subsidiary for R&D and manufacturing
- 2001.09 Relocated headquarters to Yangjae-dong
- 2004.09 Merged and absorbed subsidiary ChemPro Co., Ltd.
- 2005.04 Certified as a BGMP-compliant company
- 2005.11 Obtained BGMP/KDMF certification for Teicoplanin
- 2005.12 Certified as a corporate R&D center
- 1999.05 Established Kangsan Pharmaceutical Co., Ltd. and obtained a pharmaceutical wholesaler license
- 1999.07 Obtained license for food import and distribution

History

“Challenge”, “Creativity” and “Exploration”

2021 ~ Present

2011 ~ 2020

2006 ~ 2010

2000 ~ 2005